These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32879958)

  • 1. Gut Microbiota-Mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Sitkin S; Vakhitov T; Kononova S; Skalinskaya M; Pokrotnieks J
    Inflamm Bowel Dis; 2021 Jan; 27(2):e10-e11. PubMed ID: 32879958
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Ke J; He R; Hou X
    Inflamm Bowel Dis; 2021 Jan; 27(2):e12. PubMed ID: 33051685
    [No Abstract]   [Full Text] [Related]  

  • 3. Fucose Ameliorate Intestinal Inflammation Through Modulating the Crosstalk Between Bile Acids and Gut Microbiota in a Chronic Colitis Murine Model.
    Ke J; Li Y; Han C; He R; Lin R; Qian W; Hou X
    Inflamm Bowel Dis; 2020 May; 26(6):863-873. PubMed ID: 32010956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acid Signaling in Inflammatory Bowel Disease.
    Bromke MA; Krzystek-Korpacka M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Sitkin S; Pokrotnieks J
    Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease.
    Heinken A; Ravcheev DA; Baldini F; Heirendt L; Fleming RMT; Thiele I
    Microbiome; 2019 May; 7(1):75. PubMed ID: 31092280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis.
    Yang ZH; Liu F; Zhu XR; Suo FY; Jia ZJ; Yao SK
    World J Gastroenterol; 2021 Jun; 27(24):3609-3629. PubMed ID: 34239273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile Acids: Key Players in Inflammatory Bowel Diseases?
    Kriaa A; Mariaule V; Jablaoui A; Rhimi S; Mkaouar H; Hernandez J; Korkmaz B; Lesner A; Maguin E; Aghdassi A; Rhimi M
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: microbial transformations of human bile acids.
    Guzior DV; Quinn RA
    Microbiome; 2021 Jun; 9(1):140. PubMed ID: 34127070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total alkaloids of Sophora alopecuroides L. ameliorated murine colitis by regulating bile acid metabolism and gut microbiota.
    Jia YQ; Yuan ZW; Zhang XS; Dong JQ; Liu XN; Peng XT; Yao WL; Ji P; Wei YM; Hua YL
    J Ethnopharmacol; 2020 Jun; 255():112775. PubMed ID: 32205259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barley Leaf Insoluble Dietary Fiber Alleviated Dextran Sulfate Sodium-Induced Mice Colitis by Modulating Gut Microbiota.
    Tian M; Li D; Ma C; Feng Y; Hu X; Chen F
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33807544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?
    Pavlidis P; Powell N; Vincent RP; Ehrlich D; Bjarnason I; Hayee B
    Aliment Pharmacol Ther; 2015 Oct; 42(7):802-17. PubMed ID: 26223936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases.
    Devkota S; Chang EB
    Dig Dis; 2015; 33(3):351-6. PubMed ID: 26045269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
    Khan I; Samson SE; Grover AK
    Med Princ Pract; 2017; 26(3):201-217. PubMed ID: 28278495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
    Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
    Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral microbiota and inflammatory bowel disease].
    Zhang HN; Zhou XD; Xu X; Wang Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Aug; 37(4):443-449. PubMed ID: 31512842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut Microbiota in Inflammatory Bowel Disease.
    Sheehan D; Shanahan F
    Gastroenterol Clin North Am; 2017 Mar; 46(1):143-154. PubMed ID: 28164847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41/43 respectors.
    Shao S; Wang D; Zheng W; Li X; Zhang H; Zhao D; Wang M
    Int Immunopharmacol; 2019 Jun; 71():411-422. PubMed ID: 31059977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.